Inovio, Parker Institute for Cancer Immunotherapy enter clinical collaboration to evaluate new cancer immunotherapy combinations

Inovio Pharmaceuticals, Inc. and the Parker Institute for Cancer Immunotherapy have entered into a clinical collaboration agreement that provides for Inovio and the Parker Institute to undertake clinical...

Orchard Therapeutics Appoints Frank Thomas as Chief Financial Officer and Chief Business Officer

Orchard Therapeutics announced the appointment of Frank Thomas to the newly created position of CFO and chief business officer.Thomas brings nearly 20 years of experience in the biopharmaceutical...

Ziath to Showcase New Low-Profile 2D Barcode Scanner for Liquid Handling Systems at SLAS2018

Ziath announced it will showcase its new, cost-effective 2D barcode rack scanner, the DataPaq Mirage, at SLAS2018 (3–7 February 2018, San Diego, CA).

Biohaven to begin clinical development of BHV-5000 to treat Rett syndrome

Biohaven Pharmaceutical Holding Company Ltd. and its wholly owned subsidiary, Biohaven Pharmaceuticals, Inc. announced that the U.S. FDA has notified the Company that it may proceed with its clinical investigation of BHV-5000.

Futuragene exclusive license for RNAi technology in eucalyptus enhanced by grant of patent in brazil

FuturaGene announce that a patent has been issued in Brazil to CSIRO, which covers the downregulation of the expression of plant target genes other target...

Nuvo Pharmaceuticals Acquires U.S. Product Rights to Resultz from Piedmont Pharmaceuticals LLC

Nuvo Pharmaceuticals Inc announced that its wholly owned subsidiary, Nuvo Pharmaceuticals Ltd ( (Nuvo Ireland)has acquired the U.S. rights to Resultz...

For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
or
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2018 / Editorial Calender please click here

For the latest visit: www.worldpharmatoday.com